Search Browse Earnings

IDEAYA Biosciences, Inc. — SlamSEC

IDEAYA Biosciences, Inc.

Nasdaq:IDYA

Pharmaceutical Preparations·SOUTH SAN FRANCISCO, CA

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

$23.4M

-54.1% YoY

FY 2025

Adj. EBITDA

-$132.0M

-564.3% margin

FY 2025

Net Income

-$113.0M

-483.0% margin

FY 2025

EPS (Diluted)

-$1.96

FY 2025

Stock Price

$34.05

-2.0%

2026-03-11

52W Range

$13.45 – $39.28

P/E Ratio

-17.4x

Market Cap

$3.0B

Cash

$157.0M

FY 2025

Total Debt

—

Net Cash

$157.0M

FY 2025

Enterprise Value

$2.8B

Debt / EBITDA

1.2x

FY 2025

EV / EBITDA

-21.5x

Employees

—